Urinary leukotriene (LT) E4 in adolescents with dysmenorrhea: A pilot study

Journal of Adolescent Health

Volumn 27, Issue 3, 2000, Pages 151-154

  Harel, Zeev ^a   Lilly, Craig ^b   Riggs, Suzanne ^a   Vaz, Rosalind ^a   Drazen, Jeffrey ^b  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Adolescents; Dysmenorrhea; Urinary leukotriene E4

Indexed keywords

CREATININE; LEUKOTRIENE E4;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSMENORRHEA; FEMALE; HUMAN; MEDIATOR RELEASE; MENSTRUAL CYCLE; PILOT STUDY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; URINE LEVEL;

ADOLESCENT; DYSMENORRHEA; FEMALE; HUMANS; LEUKOTRIENE E4; MENSTRUAL CYCLE; PILOT PROJECTS; UTERINE CONTRACTION;

EID: 0033841953     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-139X(00)00123-3     Document Type: Article

References (26)

1. Klein J.R., Litt I.F. Epidemiology of adolescent dysmenorrhea. Pediatrics. 68:1981;661-664.
2. Alvin P.E., Litt I.F. Current status of etiology and management of dysmenorrhea in adolescents. Pediatrics. 70:1982;516-525.
3. Milsom I., Andersch B. Effect of various oral contraceptive combinations on dysmenorrhea. Gynecol Obstet Invest. 17:1984;284-292.
4. Owen P.R. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Am J Obstet Gynecol. 148:1984;96-103.
5. Dawood M.Y. Non-steroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. Am J Med. 84:1988;23-29.
6. Harel Z., Biro F.M., Kotenhahn R.K., et al. Supplementation with omega-3 fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. 174:1996;1335-1338.
7. Rees M.C.P., Anderson A.B.M., Demers L.M., et al. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhea. Br J Obstet Gynaecol. 91:1984;673-680.
8. Lewis R.A., Austen K.F., Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med. 323:1990;645-655.
9. 4 in the pulmonary and systemic vasculature of sheep. Bull Eur Physiol Pathol Respir. 22:1986;573-580.
10. Rees M.C.P., DI Marzo V., Tippins J.R., et al. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. J Endocrinol. 113:1987;291-295.
11. Carraher R., Hahn D.Q., Ritchie D.M., et al. Involvement of lipoxygenase products in myometrial contractions. Prostaglandins. 26:1983;23-32.
12. 4 in children with atopic asthma. Pediatr Res. 29:1991;455-459.
13. 4 levels are elevated in patients with active systemic lupus erythematosus. J Rheumatol. 19:1992;252-258.
14. 4 excretion in normal and asthmatic subjects. Am Rev Respir Dis. 148:1993;1244-1251.
15. Ibe B.O., Kurantsin-Mills J., Usha Raj J., et al. Plasma and urinary leukotrienes in sickle cell disease Possible role in the inflammatory process . Eur J Clin Invest. 24:1994;57-64.
16. 4 are elevated in active Crohn's disease. J Pediatr Gastroenterol Nutr. 20:1995;403-407.
17. 4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. J Allergy Clin Immunol. 96:1995;643-651.
18. 4 levels increase upon exposure to hypobaric hypoxia. Chest. 110:1996;946-951.
19. Cox D.J., Meyer R.G. Behavioral treatment parameters with primary dysmenorrhea. J Behav Med. 1:1978;297-310.
20. Westcott J.Y., Johnston K., Batt R.A., et al. Measurement of peptidoleukotriene in biological fluids. J Appl Physiol. 68:1990;2640-2648.
21. Nigam S., Benedetto C., Zonca M., et al. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids. 4:1991;137-141.
22. Levinson S.L. Peptidoleukotriene binding in guinea pig uterine membrane preparations. Prostaglandins. 28:1984;229-240.
23. Sampson A.P., Castling D.P., Green C.P., et al. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child. 73:1995;221-225.
24. Massey W.A., Guo C.B., Dvorak A.M., et al. Human uterine mast cells Isolation, purification, characterization, ultrastructure, and pharmacology . J Immunol. 147:1991;1621-1627.
25. Kelly R.W., Illingworth P., Baldie G., et al. Progesterone control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition. Hum Reprod. 9:1994;253-258.
26. Harris R.R., Carter G.W., Bell R.L., et al. Clinical activity of leukotriene inhibitors. Int J Immunopharmacol. 17:1995;147-156.